Changes in plaque lipid content after short-term intensive versus standard statin therapy: the YELLOW trial (reduction in yellow plaque by aggressive lipid-lowering …
Objectives: This study sought to determine the impact of short-term intensive statin therapy
on intracoronary plaque lipid content. Background: Statin therapy significantly reduces the …
on intracoronary plaque lipid content. Background: Statin therapy significantly reduces the …
Role of noninvasive testing in the clinical evaluation of women with suspected ischemic heart disease: a consensus statement from the American Heart Association
JH Mieres, M Gulati, N Bairey Merz, DS Berman… - Circulation, 2014 - Am Heart Assoc
Historically, the focus of the diagnostic evaluation for symptomatic women and men has
been the detection of an obstructive coronary stenosis requiring revascularization (as …
been the detection of an obstructive coronary stenosis requiring revascularization (as …
Thin-cap fibroatheroma and microchannel findings in optical coherence tomography correlate with subsequent progression of coronary atheromatous plaques
Aims Morphological characteristics of non-significant coronary plaques (NSCPs) that
develop rapid progression have not been fully elucidated. The aim of this study was to clarify …
develop rapid progression have not been fully elucidated. The aim of this study was to clarify …
Near-infrared spectroscopy predicts cardiovascular outcome in patients with coronary artery disease
RM Oemrawsingh, JM Cheng, HM García-García… - Journal of the American …, 2014 - jacc.org
Background: Near-infrared spectroscopy (NIRS) is capable of identifying lipid core-
containing plaques, which can subsequently be quantified as a lipid core burden index …
containing plaques, which can subsequently be quantified as a lipid core burden index …
[HTML][HTML] 2017 Taiwan lipid guidelines for high risk patients
YH Li, KC Ueng, JS Jeng, MJ Charng, TH Lin… - Journal of the Formosan …, 2017 - Elsevier
In Taiwan, the prevalence of hyperlipidemia increased due to lifestyle and dietary habit
changes. Low density lipoprotein cholesterol (LDL-C) and non-high density lipoprotein …
changes. Low density lipoprotein cholesterol (LDL-C) and non-high density lipoprotein …
Concomitant coronary atheroma regression and stabilization in response to lipid-lowering therapy
Background The frequency, characteristics, and outcomes of patients treated with high-
intensity lipid-lowering therapy and showing concomitant atheroma volume reduction, lipid …
intensity lipid-lowering therapy and showing concomitant atheroma volume reduction, lipid …
Non-HDL cholesterol and triglycerides: implications for coronary atheroma progression and clinical events
Objectives—Non–high-density lipoprotein cholesterol (non-HDLC) levels reflect the full
burden of cholesterol transported in atherogenic lipoproteins. Genetic studies suggest a …
burden of cholesterol transported in atherogenic lipoproteins. Genetic studies suggest a …
Effect of evolocumab on coronary plaque composition
Background: Incremental low-density lipoprotein (LDL) cholesterol lowering with the
proprotein convertase subtilisin kexin type 9 inhibitor evolocumab regresses coronary …
proprotein convertase subtilisin kexin type 9 inhibitor evolocumab regresses coronary …
Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors
Background and aims The atherogenic index of plasma (AIP) has been suggested as a
marker of plasma atherogenicity. This study aimed to assess the association between AIP …
marker of plasma atherogenicity. This study aimed to assess the association between AIP …
Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study
L Räber, M Taniwaki, S Zaugg, H Kelbæk… - European heart …, 2015 - academic.oup.com
Aim The effect of long-term high-intensity statin therapy on coronary atherosclerosis among
patients with acute ST-segment elevation myocardial infarction (STEMI) is unknown. The …
patients with acute ST-segment elevation myocardial infarction (STEMI) is unknown. The …